Raúl Insa, MD, PhD, MBA
Founder, President and CEO
Dr. Insa has been working for more than 20 years in multinational pharmaceutical companies, such as Parke-Davis (now Pfizer), UCB Pharma, Uriach Group (now Palau Pharma) and ISDIN (from Esteve Group). His experience is related to drug development from drug identification to commercialization, including mainly clinical research and licensing. He was involved in the development of products like Quinapril, Tacrine, Cetirizin, Levetiracetam, Rupatadin, Dersalazine, Cimicoxib, Albaconazole, Gemfibrozil, Gabapentin, Piracetam, Levocetirizine, Nanocapsuled Cyclosporin, Disitertide, and others. He received his Medical training and his PhD in Clinical Neurology at the University of Alicante, Spain; an MBA from ESADE Business School in Barcelona and an Executive Education Program from IESE, Barcelona. He has also attended a couple of biotech leadership programs from Harvard Business School, Boston. His background includes more than 45 publications and papers, 7 chapters in books, 87 congress communications and 9 pharmaceutical patents.
Martí Dalmases, MD, PhD, MBA
Martí is a Medical Doctor, PhD degree and MBA. He has foster, lead and managed research and innovation projects, both public and private. He has been an entrepreneurship participating in the foundation of different startup companies. Today he collaborates in tech transfer projects from different sectors, and he is the CEO of Nanosel (cancer drug delivery vehicle) SL, and Ahead Therapeutics SL (auto-immune disorders treatment).
Alberto Stampa, PhD
Chemist and Pharma Industry Expert. Founder of Medichem (API manufacturer) and Combino Pharm (generics company).
Antoni Salgado, BSc
Pharmacist and Regulatory Expert, has worked for Uriach, UCB, Lundbeck and Sobi.
Marc Sabé, BA
Large investment experience in technological companies, including some biotechs.
Raj Airey, BSc, BA
Chief Strategy Officer
Raj is a venture developer, advisor and investor in early stage biotech and medical device businesses with extensive experience in the health sector and senior leadership roles with blue chip firms like Pfizer and Baxter. Raj brings 28 years of operating experience in the healthcare industry in various parts of the world, including the UK, Belgium, Hungary, Slovakia, Poland, Spain and India/South East Asia. Raj is also an entrepreneur, having founded several companies and exited two in the healthcare space. He has also been involved in many fund raising and licensing deals across the globe. He founded Wizzcare Home Health Solutions, a pioneer in home care and tele-health Company in India, which was sold to Indian’s leading E-health business. He is also a co-founder of Health Start, India’s first Healthcare accelerator. The accelerator has invested extensively in portfolio health companies, and Raj is an active board member and mentor to some of them. Raj is a post graduate from the London University and executive programs from Harvard Business School and INSEAD, as well as an Accredited Executive Coach of the International Coaching Federation.
Joaquim Trias, PhD
Scientific Advisory Board
25 years in multiple successful biotech startups, 3 approved drugs, 2 drugs brought to Phase 3, 4 IPOs, and 2 M&A.
Leonard Brandt, BA, MBA
Strategic Advisory Board
Ex-General Partner at Norwest Ventures and co-founder of CNS Response Inc, Mill City Venture Consulting Inc, , HDI, Empro Vascular and others.